COCP (STOCKS)
Cocrystal Pharma, Inc. Common Stock
$0.960000
+0.002800 (+0.29%)
Prev close: $0.957200
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sam Lee
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $13.18M
- Employees
- 11
- P/E (TTM)
- -1.02
- P/B (TTM)
- 1.63
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $97.00K |
| Operating Expenses | $9.77M |
| Depreciation and Amortization | $87.00K |
| Research and Development | $5.47M |
| Other Operating Expenses | $4.22M |
| Operating Income/Loss | -$9.77M |
| Income/Loss From Continuing Operations After Tax | -$9.67M |
| Income/Loss From Continuing Operations Before Tax | -$9.67M |
| Net Income/Loss | -$9.67M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.67M |
| Net Income/Loss Available To Common Stockholders, Basic | -$9.67M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.93 |
| Diluted Earnings Per Share | -$0.94 |
| Basic Average Shares | 10,449,000 |
| Diluted Average Shares | 31,339,000 |
| Assets | $10.45M |
| Current Assets | $8.78M |
| Noncurrent Assets | $1.66M |
| Fixed Assets | $106.00K |
| Other Non-current Assets | $1.56M |
| Liabilities | $2.78M |
| Current Liabilities | $1.52M |
| Accounts Payable | $745.00K |
| Wages | $127.00K |
| Other Current Liabilities | $648.00K |
| Noncurrent Liabilities | $1.26M |
| Equity | $7.67M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.67M |
| Liabilities And Equity | $10.45M |
| Net Cash Flow From Operating Activities | -$9.62M |
| Net Cash Flow From Operating Activities, Continuing | -$9.62M |
| Net Cash Flow From Investing Activities | -$12.00K |
| Net Cash Flow From Investing Activities, Continuing | -$12.00K |
| Net Cash Flow From Financing Activities | $9.63M |
| Net Cash Flow From Financing Activities, Continuing | $9.63M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$9.67M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.67M |
| Other Comprehensive Income/Loss | $0.00 |